All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-33920487

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	33920487	A222V	S	S	COVID-19	G R	View
2	33920487	A220V	N	N	COVID-19	G R	View
3	33920487	Q57H	ORF3a	ORF3a	COVID-19	G R	View
4	33920487	T85I	NSP2	ORF1a	COVID-19	G R	View
5	33920487	D614G	S	S	COVID-19	G R	View
6	33920487	P323L	RdRp	ORF1b	COVID-19	G R	View
7	33920487	L18F	S	S	COVID-19	R	View
8	33920487	N439K	S	S	COVID-19	R	View
9	33920487	S477N	S	S	COVID-19	R	View
10	33920487	G172V	ORF3a	ORF3a	COVID-19	R	View
11	33920487	P67S	N	N	COVID-19	R	View
12	33920487	S194L	N	N	COVID-19	R	View
13	33920487	P199L	N	N	COVID-19	R	View
14	33920487	R203K	N	N	COVID-19	R	View
15	33920487	G204R	N	N	COVID-19	R	View
16	33920487	M234I	N	N	COVID-19	R	View
17	33920487	A376T	N	N	COVID-19	R	View
18	33920487	I120F	NSP2	ORF1a	COVID-19	R	View
19	33920487	K218R	NSP13	ORF1b	COVID-19	R	View
20	33920487	E261D	NSP13	ORF1b	COVID-19	R	View
21	33920487	H290Y	NSP13	ORF1b	COVID-19	R	View
22	33920487	A185S	NSP12	ORF1b	COVID-19	R	View
23	33920487	V776L	NSP12	ORF1b	COVID-19	R	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.